Aelea Commodities IPO vs Nephro Care India IPO

Comparision between Aelea Commodities IPO and Nephro Care India IPO.

IPO Details

Aelea Commodities IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Nephro Care India IPO is a SME Book Built Issue proposed to list at NSE SME.

	Aelea Commodities IPO	Nephro Care India IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Ekadrisht Capital Private Limited	Corporate Capitalventures Pvt Ltd
Registrar	Maashitla Securities Private Limited	Bigshare Services Pvt Ltd
Market Maker	Ss Corporate Securities Limited	Ss Corporate Securities Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Aelea Commodities IPO is up to ₹51.00 Cr whereas the issue size of the Nephro Care India IPO is up to ₹41.26 Cr. The final issue price of Aelea Commodities IPO is ₹95.00 per share and of Nephro Care India IPO is ₹90.00 per share.

	Aelea Commodities IPO	Nephro Care India IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹91.00 per share	₹85.00 per share
Issue Price (Upper)	₹95.00 per share	₹90.00 per share
Issue Price (Final)	₹95.00 per share	₹90.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	1200 shares	1600 shares
Fresh Issue Size	53,68,800 shares	45,84,000 shares
Fresh Issue Size (Amount)	up to ₹51.00 Cr	up to ₹41.26 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	53,68,800 shares	45,84,000 shares
Issue Size Total (Amount)	up to ₹51.00 Cr	up to ₹41.26 Cr

IPO Timetable

Aelea Commodities IPO opens on Jul 12, 2024, while Nephro Care India IPO opens on Jun 28, 2024. The closing date of Aelea Commodities IPO and Nephro Care India IPO is Jul 16, 2024, and Jul 02, 2024, respectively.

	Aelea Commodities IPO	Nephro Care India IPO
Anchor Bid Date	Jul 11, 2024	Jun 27, 2024
Issue Open	Jul 12, 2024	Jun 28, 2024
Issue Close	Jul 16, 2024	Jul 02, 2024
Basis Of Allotment (Tentative)	Jul 18, 2024	Jul 03, 2024
Initiation of Refunds (Tentative)	Jul 19, 2024	Jul 04, 2024
Credit of Share (Tentative)	Jul 19, 2024	Jul 04, 2024
Listing date (Tentative)	Jul 22, 2024	Jul 05, 2024
Anchor Lockin End date 1	Aug 17, 2024	Aug 02, 2024
Anchor Lockin End date 2	Oct 16, 2024	Oct 01, 2024

Financials

Aelea Commodities IPO P/E ratio is 11.62, as compared to Nephro Care India IPO P/E ratio of 55.15.

Aelea Commodities IPO

Nephro Care India IPO

Financial

Aelea Commodities Limited Financial Information (Restated Consolidated)

Aelea Commodities Limited's revenue increased by 31.2% and profit after tax (PAT) rose by 539.22% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 May 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	11,641.28	10,653.47	9,876.85	7,028.03	5,041.15
Revenue	2,758.47	14,450.77	11,014.44	10,550.85	47,595.26
Profit After Tax	280.36	1,222.32	191.22	1,063.11	1,108.51
Net Worth	4,875.32	4,592.89	3,383.00	3,060.89	1,940.51
Reserves and Surplus	3,375.32	3,092.89	3,351.00	3,029.53	1,932.69
Total Borrowing	4,120.36	4,077.32	3,327.40	2,130.76	1,096.14
Amount in ₹ Lakhs

Nephro Care India Limited Financial Information (Restated)

Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	2,029.85	831.11	462.93	112.84
Revenue	1,989.60	1,709.51	342.70	183.26
Profit After Tax	340.04	194.24	-0.98	8.87
Net Worth	1,392.32	243.76	49.52	1.50
Reserves and Surplus	1,332.81	193.76	-0.48	0.50
Total Borrowing		246.39	253.74	69.27
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

86.45%

85.02%

Promoter Shareholding (Post-Issue)

63.66%

61.39%

P/E Ratio

11.62

55.15

Market Cap

₹193.03 Cr.

₹148.38 Cr.

ROE

5.92%%

41.57%%

ROCE

5.72%%

36.56%%

Debt/Equity

0.85

EPS

₹8.18

₹1.63

RoNW

5.75%%

24.42%%

Shares Offered

In the Aelea Commodities IPO retail investors (RII) are offered 17,85,600 shares while in Nephro Care India IPO retail investors are offered 17,85,600 shares. Qualified institutional buyers (QIB) are offered 10,20,000 shares in Aelea Commodities IPO and 8,25,600 shares in Nephro Care India IPO.

	Aelea Commodities IPO	Nephro Care India IPO
Anchor Investor Reserveration	15,28,800 shares	12,38,400 shares
Market Maker Reserveration	2,68,800 shares	2,30,400 shares
QIB	10,20,000 shares	8,25,600 shares
NII	7,65,600 shares	6,19,200 shares
RII	17,85,600 shares	14,44,800 shares
Employee	0 shares	0 shares
Others
Total	35,71,200 shares	31,15,200 shares

Bids Received (Subscription)

Aelea Commodities IPO subscribed 195.83x in total, whereas Nephro Care India IPO subscribed 715.78x.

	Aelea Commodities IPO	Nephro Care India IPO
QIB (times)	104.22x	245.14x
NII (times)	389.87x	1,787.19x
Big NII (times)
Small NII (times)
RII (times)	164.95x	634.12x
Employee (times)
Other (times)
Total (times)	195.83x	715.78x

Compare with others

Aelea Commodities IPO	Nephro Care India IPO
Tunwal E-Motors IPO	Sahaj Solar IPO
Three M Paper Boards IPO	Aelea Commodities IPO
Prizor Viztech IPO	Ganesh Green Bharat IPO
Sati Poly Plast IPO	Effwa Infra and Research IPO
Sahaj Solar IPO	Ambey Laboratories IPO
Ganesh Green Bharat IPO	Diensten Tech IPO
Effwa Infra and Research IPO	Visaman Global Sales IPO
Ambey Laboratories IPO	Mason Infratech IPO
Nephro Care India IPO	Petro Carbon and Chemicals IPO
Diensten Tech IPO	Sylvan Plyboard IPO

Comments

Add a public comment...